USD
$0.00
(0.00%
)At Close (As of Sep 16, 2025)
$135.16M
Market Cap
-
P/E Ratio
-5.96
EPS
$19.69
52 Week High
$2.92
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$259K |
Total Revenue | $0 |
Cost Of Revenue | $259K |
Costof Goods And Services Sold | $259K |
Operating Income | -$41M |
Selling General And Administrative | $18M |
Research And Development | $22M |
Operating Expenses | $40M |
Investment Income Net | - |
Net Interest Income | -$3.7M |
Interest Income | $2.1M |
Interest Expense | $5.8M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $3.3M |
Income Before Tax | -$39M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$39M |
Comprehensive Income Net Of Tax | - |
Ebit | -$44M |
Ebitda | -$41M |
Net Income | -$39M |
Field | Value (USD) |
---|---|
Total Assets | $55M |
Total Current Assets | $53M |
Cash And Cash Equivalents At Carrying Value | $51M |
Cash And Short Term Investments | $51M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $2.7M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $1.6M |
Other Non Current Assets | - |
Total Liabilities | $43M |
Total Current Liabilities | $17M |
Current Accounts Payable | $628K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $11M |
Total Non Current Liabilities | $26M |
Capital Lease Obligations | $1.8M |
Long Term Debt | $20M |
Current Long Term Debt | $10M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $32M |
Other Current Liabilities | $5M |
Other Non Current Liabilities | $4.7M |
Total Shareholder Equity | $12M |
Treasury Stock | - |
Retained Earnings | -$668M |
Common Stock | $6K |
Common Stock Shares Outstanding | $5.5M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$29M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $259K |
Capital Expenditures | $208K |
Change In Receivables | - |
Change In Inventory | $0 |
Profit Loss | - |
Cashflow From Investment | -$208K |
Cashflow From Financing | $30M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$39M |
Field | Value (USD) |
---|---|
Gross Profit | -$259K |
Total Revenue | $0 |
Cost Of Revenue | $259K |
Costof Goods And Services Sold | $259K |
Operating Income | -$41M |
Selling General And Administrative | $18M |
Research And Development | $22M |
Operating Expenses | $40M |
Investment Income Net | - |
Net Interest Income | -$3.7M |
Interest Income | $2.1M |
Interest Expense | $5.8M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $3.3M |
Income Before Tax | -$39M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$39M |
Comprehensive Income Net Of Tax | - |
Ebit | -$44M |
Ebitda | -$41M |
Net Income | -$39M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts.